These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 26260960)
21. DNA vaccines for emerging infectious diseases: what if? Whalen RG Emerg Infect Dis; 1996; 2(3):168-75. PubMed ID: 8903226 [TBL] [Abstract][Full Text] [Related]
22. Novel approaches to tuberculosis prevention: DNA vaccines. Rivas-Santiago B; Cervantes-Villagrana AR Scand J Infect Dis; 2014 Mar; 46(3):161-8. PubMed ID: 24450840 [TBL] [Abstract][Full Text] [Related]
23. DNA vaccination and gene therapy: optimization and delivery for cancer therapy. Bodles-Brakhop AM; Draghia-Akli R Expert Rev Vaccines; 2008 Sep; 7(7):1085-101. PubMed ID: 18767956 [TBL] [Abstract][Full Text] [Related]
24. DNA vaccines: a role for liposomes. Gregoriadis G Curr Opin Mol Ther; 1999 Feb; 1(1):39-42. PubMed ID: 11249682 [TBL] [Abstract][Full Text] [Related]
25. Optimization and delivery of plasmid DNA for vaccination. Jechlinger W Expert Rev Vaccines; 2006 Dec; 5(6):803-25. PubMed ID: 17184219 [TBL] [Abstract][Full Text] [Related]
26. Development of dengue DNA vaccines. Danko JR; Beckett CG; Porter KR Vaccine; 2011 Sep; 29(42):7261-6. PubMed ID: 21777640 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Otten G; Schaefer M; Doe B; Liu H; Srivastava I; zur Megede J; O'Hagan D; Donnelly J; Widera G; Rabussay D; Lewis MG; Barnett S; Ulmer JB Vaccine; 2004 Jun; 22(19):2489-93. PubMed ID: 15193413 [TBL] [Abstract][Full Text] [Related]
28. DNA vaccines onward and upward! 20 years and counting! Highlights of the DNA vaccines 2012 meeting. Ugen K; Weiner DB Hum Vaccin Immunother; 2013 Oct; 9(10):2038-40. PubMed ID: 24131943 [No Abstract] [Full Text] [Related]
29. Tetravalent DNA vaccine product as a vaccine candidate against dengue. Porter KR; Teneza-Mora N; Raviprakash K Methods Mol Biol; 2014; 1143():283-95. PubMed ID: 24715294 [TBL] [Abstract][Full Text] [Related]
30. DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant. Bellier B; Dalba C; Clerc B; Desjardins D; Drury R; Cosset FL; Collins M; Klatzmann D Vaccine; 2006 Mar; 24(14):2643-55. PubMed ID: 16481074 [TBL] [Abstract][Full Text] [Related]
31. Bacterial vectors and delivery systems in cancer therapy. Gardlik R; Fruehauf JH IDrugs; 2010 Oct; 13(10):701-6. PubMed ID: 20878592 [TBL] [Abstract][Full Text] [Related]
32. DNA fusion gene vaccines against cancer: from the laboratory to the clinic. Stevenson FK; Rice J; Ottensmeier CH; Thirdborough SM; Zhu D Immunol Rev; 2004 Jun; 199():156-80. PubMed ID: 15233733 [TBL] [Abstract][Full Text] [Related]
33. DNA vaccines for biodefence. Garmory HS; Perkins SD; Phillpotts RJ; Titball RW Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877 [TBL] [Abstract][Full Text] [Related]
35. DNA vaccines against cancer. Stan R; Wolchok JD; Cohen AD Hematol Oncol Clin North Am; 2006 Jun; 20(3):613-36. PubMed ID: 16762727 [TBL] [Abstract][Full Text] [Related]
36. CpG motifs for optimization of DNA vaccines. Davis HL Dev Biol (Basel); 2000; 104():165-9. PubMed ID: 11713816 [TBL] [Abstract][Full Text] [Related]
37. Priming of CTL responses by DNA vaccines: direct transfection of antigen presenting cells versus cross-priming. Ulmer JB; Otten GR Dev Biol (Basel); 2000; 104():9-14. PubMed ID: 11713829 [TBL] [Abstract][Full Text] [Related]
38. Strategies for improving DNA vaccine performance. Iurescia S; Fioretti D; Rinaldi M Methods Mol Biol; 2014; 1143():21-31. PubMed ID: 24715280 [TBL] [Abstract][Full Text] [Related]
39. Controlled release of DNA vaccines: does in vitro release profile correlate with immune response? Balenga NA Med Hypotheses; 2006; 66(4):864-5. PubMed ID: 16406686 [No Abstract] [Full Text] [Related]